Skip to content

Press Releases: ArisGlobal’s LifeSphere Safety Leaders to Discuss Current Landscape and Future of Data, Automation, and Analytics in Pharmacovigilance at World Drug Safety Congress

Market leading safety platform to lead six sessions across Europe and America.

MIAMI, FL – September 20, 2022 – ArisGlobal, the leading provider of life sciences software that automates core drug development functions with its end-to-end technology platform LifeSphere®, today announces a series of technology and data-centric sessions at the 2022 World Drug Safety Congress (WDS) events, including a keynote by Chief Commercial Officer Aman Wasan at WDS Europe, followed by WDS Americas, featuring a keynote session by LifeSphere Safety product leader and acclaimed industry veteran, Beena Wood.   

Kicking off the world tour is a series of conversations at WDS Europe, with three informative sessions over two days. Attendees will hear Wasan, along with other innovative speakers, discuss the data and analytics opportunities in pharmacovigilance, including timely topics such as using intelligent analytics to unlock insights in data and how ArisGlobal’s LifeSphere solutions are advancing pharmacovigilance today and driving future innovation.  

Following the company’s signature event, Breakthrough, ArisGlobal’s LifeSphere Safety product leaders will once again take the stage at the WDS Americas event for three more sessions. Notably, ArisGlobal will lead a conversation with safety leaders from Boehringer Ingelheim, Moderna, and PMI on a panel discussing real-life results from pharmacovigilance automation.  

“We’re excited to speak at World Drug Safety and share our view on the future of R&D IT strategy and how technology plays a key role in the digital transformation of the IT ecosystem within life sciences,” says Wasan. “ArisGlobal’s LifeSphere is leading strategic innovation to continue advancing the industry, and we’re proud to usher in the next generation of technology and data.”  

Recently, ArisGlobal acquired an advanced intelligent analytics engine from Boehringer Ingelheim, named LifeSphere Clarity, which will be shown at ArisGlobal’s Breakthrough conference and will debut as a commercially available product in 2023 and bring enhanced and unmatched data intelligence capabilities to life sciences. 

About LifeSphere: LifeSphere® is the trusted partner for global pharmaceutical and biotechnology companies, health authorities, and contract research organizations. Helping accelerate product development, organize clinical trials, manage compliance, and streamline collaboration across teams, LifeSphere empowers safer, faster life science breakthroughs. The flagship platform of ArisGlobal, LifeSphere is a market-leading solution built on 40 years of industry partnership and continues to evolve in collaboration with hundreds of trusted customers worldwide. Visit lifesphere.arisglobal.com. 

Breakthrough 2022 JOIN US FOR BREAKTHROUGH 2022.         Learn more and register today